BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 29473962)

  • 1. Postoperative low hepatitis C virus load predicts long-term outcomes after hepatectomy for hepatocellular carcinoma.
    Sasaki K; Shindoh J; Nishioka Y; Sugawara T; Margonis GA; Andreatos N; Pawlik TM; Hashimoto M
    J Surg Oncol; 2018 Apr; 117(5):902-911. PubMed ID: 29473962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low hepatitis C viral load predicts better long-term outcomes in patients undergoing resection of hepatocellular carcinoma irrespective of serologic eradication of hepatitis C virus.
    Shindoh J; Hasegawa K; Matsuyama Y; Inoue Y; Ishizawa T; Aoki T; Sakamoto Y; Sugawara Y; Makuuchi M; Kokudo N
    J Clin Oncol; 2013 Feb; 31(6):766-73. PubMed ID: 23129744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High viral load is associated with poor overall and recurrence-free survival of hepatitis B virus-related hepatocellular carcinoma after curative resection: a prospective cohort study.
    Yang T; Lu JH; Zhai J; Lin C; Yang GS; Zhao RH; Shen F; Wu MC
    Eur J Surg Oncol; 2012 Aug; 38(8):683-91. PubMed ID: 22621971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum antibody titers against hepatitis C virus and postoperative intrahepatic recurrence of hepatocellular carcinoma.
    Uemura M; Sasaki Y; Yamada T; Gotoh K; Eguchi H; Yano M; Ohigashi H; Ishikawa O; Imaoka S
    Ann Surg Oncol; 2014 May; 21(5):1719-25. PubMed ID: 24464342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of viral hepatitis on outcomes after liver resection for hepatocellular carcinoma: results from a north american center.
    Lee JJ; Kim PT; Fischer S; Fung S; Gallinger S; McGilvray I; Moulton CA; Wei AC; Greig PD; Cleary SP
    Ann Surg Oncol; 2014 Aug; 21(8):2708-16. PubMed ID: 24806113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic roles of preoperative α-fetoprotein and des-γ-carboxy prothrombin in hepatocellular carcinoma patients.
    Meguro M; Mizuguchi T; Nishidate T; Okita K; Ishii M; Ota S; Ueki T; Akizuki E; Hirata K
    World J Gastroenterol; 2015 Apr; 21(16):4933-45. PubMed ID: 25945007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of Hepatocellular Carcinoma Recurrence in Patients With Low Hepatitis B Virus DNA Levels and High Preoperative Hepatitis B Surface Antigen Levels.
    Huang G; Lau WY; Zhou WP; Shen F; Pan ZY; Yuan SX; Wu MC
    JAMA Surg; 2014 Jun; 149(6):519-27. PubMed ID: 24696192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Achievement of a Sustained Virological Response Either Before or After Hepatectomy Improves the Prognosis of Patients with Primary Hepatitis C Virus-Related Hepatocellular Carcinoma.
    Okamura Y; Sugiura T; Ito T; Yamamoto Y; Ashida R; Ohgi K; Uesaka K
    Ann Surg Oncol; 2019 Dec; 26(13):4566-4575. PubMed ID: 31602577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiviral Therapy Inhibits Viral Reactivation and Improves Survival after Repeat Hepatectomy for Hepatitis B Virus-Related Recurrent Hepatocellular Carcinoma.
    Huang S; Xia Y; Lei Z; Zou Q; Li J; Yang T; Wang K; Yan Z; Wan X; Shen F
    J Am Coll Surg; 2017 Mar; 224(3):283-293.e4. PubMed ID: 27923614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of sustained virological response to interferon therapy for hepatitis C to the hepatectomy for primary hepatocellular carcinoma.
    Tsujita E; Maeda T; Kayashima H; Harada N; Tsutsui S; Matsuda H; Kinjo N; Ikeda Y; Morita M; Ishida T
    Hepatogastroenterology; 2015; 62(137):157-63. PubMed ID: 25911888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Posthepatectomy HBV reactivation in hepatitis B-related hepatocellular carcinoma influences postoperative survival in patients with preoperative low HBV-DNA levels.
    Huang G; Lai EC; Lau WY; Zhou WP; Shen F; Pan ZY; Fu SY; Wu MC
    Ann Surg; 2013 Mar; 257(3):490-505. PubMed ID: 22868358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive value of preoperative and postoperative peripheral lymphocyte difference in hepatitis B virus-related hepatocellular cancer patients: Based on the analysis of dynamic nomogram.
    Luo D; Li H; Yu H; Zhang M; Hu J; Jin C; Chua M; Han B
    J Surg Oncol; 2020 Dec; 122(8):1553-1568. PubMed ID: 32862430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amino acid substitutions in the hepatitis C virus core region are associated with postoperative recurrence and survival of patients with HCV genotype 1b-associated hepatocellular carcinoma.
    Toyoda H; Kumada T; Kaneoka Y; Maeda A
    Ann Surg; 2011 Aug; 254(2):326-32. PubMed ID: 21709542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Impact of the Hepatitis B Core Antibody Status on Recurrence in Patients with Non-B Non-C Hepatocellular Carcinoma after Curative Surgery.
    Okamura Y; Sugiura T; Ito T; Yamamoto Y; Ashida R; Uesaka K
    Dig Surg; 2018; 35(3):243-251. PubMed ID: 28810252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgical outcomes for hepatocellular carcinoma detected after hepatitis C virus eradiation by direct-acting antivirals.
    Tanaka S; Shinkawa H; Tamori A; Takemura S; Takahashi S; Amano R; Kimura K; Ohira G; Kawada N; Kubo S
    J Surg Oncol; 2020 Dec; 122(8):1543-1552. PubMed ID: 32856301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Viral Etiology on Postoperative De Novo Recurrence After Hepatectomy for Hepatocellular Carcinoma in Cirrhotic Patients.
    Sasaki K; Shindoh J; Nishioka Y; Margonis GA; Sugawara T; Andreatos N; Hashimoto M; Pawlik TM
    J Gastrointest Surg; 2017 Mar; 21(3):487-495. PubMed ID: 28050767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic factors affecting postoperative survival of patients with solitary small hepatocellular carcinoma.
    Cai MY; Wang FW; Li CP; Yan LX; Chen JW; Luo RZ; Yun JP; Zeng YX; Xie D
    Chin J Cancer; 2016 Aug; 35(1):80. PubMed ID: 27527497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HBV DNA and HBsAg levels as risk predictors of early and late recurrence after curative resection of HBV-related hepatocellular carcinoma.
    Sohn W; Paik YH; Kim JM; Kwon CH; Joh JW; Cho JY; Gwak GY; Choi MS; Lee JH; Koh KC; Paik SW; Yoo BC
    Ann Surg Oncol; 2014 Jul; 21(7):2429-35. PubMed ID: 24619495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of pegylated interferon therapy on outcomes of patients with hepatitis C virus-related hepatocellular carcinoma after curative hepatic resection.
    Tanimoto Y; Tashiro H; Aikata H; Amano H; Oshita A; Kobayashi T; Kuroda S; Tazawa H; Takahashi S; Itamoto T; Chayama K; Ohdan H
    Ann Surg Oncol; 2012 Feb; 19(2):418-25. PubMed ID: 21710324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of surgical outcomes for small hepatocellular carcinoma in patients with hepatitis B versus hepatitis C: a Chinese experience.
    Li Q; Li H; Qin Y; Wang PP; Hao X
    J Gastroenterol Hepatol; 2007 Nov; 22(11):1936-41. PubMed ID: 17914973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.